Andrea Necchi

#SURE02 Trial: A patient-driven, bladder-sparing approach for #MIBC. @AndreaNecchi @MyUniSR joins @ERPlimackMD @FoxChaseCancer to discuss the combination of sacituzumab govitecan + pembrolizumab in a bladder-sparing approach for muscle-invasive #BladderCancer. #WatchNow >…

The Post-ASCO 2025 GU Cancer Highlights virtual webinar by @VJOncology WATCH NOW On Demand 👉 bit.ly/3UmZI7Q Featuring expert presentations and discussions on key GU cancer abstracts from ASCO 2025. @neerajaiims @ERPlimackMD @AndreaNecchi

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer jnj.com/media-center/p…

Molecular characterization of residual muscle-invasive bladder cancer identifies a scar-like transcriptomicprofile with favorable prognosis after neoadjuvant therapy aacrjournals.org/clincancerres/…

Top #GUCancer Oncologists for Q2 2025, curated by @Larvol CLIN. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights | @DrChoueiri | @DrYukselUrun |…

Understanding the Utility of Circulating Tumor DNA for Bladder Preservation in Patients With Muscle-Invasive Bladder Cancer ⁦@ASCO⁩ #DailyNews #ctDNA #BLADDERCANCER dailynews.ascopubs.org/do/understandi…

DAY TWO 🚨 #GUARDSymposium2025 Presentation by Dr. @AndreaNecchi 🇮🇹 NeoAdjuvant 🆚Adjuvant🆚PeriOperative Therapy for Muscle Invasive #BladderCancer @tompowles1 @ProfSyedHussain @MattGalsky @AndreaNecchi @DrFelixGuerrero @malvarezmaestro @urbano_anido @JaviMolinaC @Dav_Lorente…

Radiation vs systemic therapy for isolated pelvic recurrence after cystectomy. @UroDocAsh moderates a debate between @AndreaNecchi @SanRaffaeleMI & Comron Hassanzadeh, MD, MPH @MDAndersonNews. Comron Hassanzadeh backs pelvic radiation for isolated recurrence, while Andrea Necchi…

Impact of molecular androgen and estrogen response scores on outcomes following neoadjuvant pembrolizumab in muscle-invasive #BladderCancer aacrjournals.org/clincancerres/… This post-hoc analysis of the PURE-01 trial investigated the influence of androgen and estrogen genomic signatures…

STARTING NOW‼️#GUARDSymposium2025 Join us ONLINE for the GUARD Symposium🇪🇸 featuring interactive workshops where experts collaboratively discuss real-world genitourinary cancer cases. REGISTER👉 events.tacticsmd.net/guard-internat… ⭐️FREE VIRTUAL Admission for LMIC's & LATAM Colleagues⭐️…

Video in @UroToday: @zklaassen_md interviews @AndreaNecchi about MRI radiomics analysis from the PURE-01 study: 3 cycles of neoadjuvant pembrolizumab in MIBC with pre- and post-treatment MRI imaging in 112 patients. Click to watch: urotoday.com/categories-med…

Thank you @AndreaNecchi for an outstanding VP with us at @UofTUrology. Tour-de-force overview of the current landscape of NMIBC and MIBC and the importance of multi-disciplinary management in bladder cancer!